EXORPHIA
Latest round
- Seed
Last raised
- Apr 2021
Total raised
- $2.8M
Investors
- 1
About EXORPHIA
Based in Tokyo, Japan, and founded in 2019, EXORPHIA Inc. develops novel medicine using extracellular vesicles. As of 2023, the company is headed by its CEO Koji Guchiishi, who founded the firm too. The company offers the INPACT-EVTM platform technology to characterize, concentrate, and purify exosomes. It engages itself in the research and development, manufacture, and sale of human cell-derived exosome drugs. Exosomes are a method of delivering medications to the body. It can effectively transfer diverse functional molecules derived from cells, such as microRNAs and proteins, to their intended targets. In? August 2025, EXORPHIA Inc.
Who invested in EXORPHIA
1 investor across 1 round
See all investors in EXORPHIA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 12, 2021
Amount
$2.8M
Investors
Questions about EXORPHIA
Who invested in EXORPHIA?
EXORPHIA has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EXORPHIA raised?
EXORPHIA has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EXORPHIA last raise money?
EXORPHIA's most recent round on record is a Seed, in Apr 2021.
What does EXORPHIA do?
Based in Tokyo, Japan, and founded in 2019, EXORPHIA Inc.
Where is EXORPHIA headquartered?
EXORPHIA is headquartered in Tokyo, Japan.
Which VCs invest in companies like EXORPHIA?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at EXORPHIA's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like EXORPHIA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.